Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
about
Immunomodulation in sepsis: state of the art and future perspectiveIntravenous immunoglobulin for treating sepsis, severe sepsis and septic shockThe role of genetics and antibodies in sepsisNew aspects in the management of pneumoniaUse of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.Management and Novel Adjuncts of Necrotizing Soft Tissue Infections.Serum IgG levels and mortality in patients with severe sepsis and septic shock : The SBITS data.Intravenous immunoglobulin for treating sepsis and septic shock.Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conferencePhysiological IgM class catalytic antibodies selective for transthyretin amyloid.Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome.Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency MedicineRisk factors for death after sepsis in patients immunosuppressed before the onset of sepsis.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Catheter-related Candida bloodstream infection in intensive care unit patients: a subgroup analysis of the China-SCAN studyIntravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial.Efficacy of single-dose intravenous immunoglobulin administration for severe sepsis and septic shock.The Japanese guidelines for the management of sepsis.Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study.Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses.Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspectiveImmunoglobulin replacement therapy in children.Bioartificial Therapy of Sepsis: Changes of Norepinephrine-Dosage in Patients and Influence on Dynamic and Cell Based Liver Tests during Extracorporeal TreatmentsClinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology.Management of sepsis in neutropenic patients: guidelines from the infectious diseases working party of the German Society of Hematology and Oncology.Current management of sepsis in critically ill adult patients.Immunomodulatory therapy for sepsis: an update.Immune-modulating interventions in critically ill septic patients: pharmacological options.Sepsis immunopathology: perspectives of monitoring and modulation of the immune disturbances.Immunoglobulins in adult sepsis and septic shock.The immune response: targets for the treatment of severe sepsis.Septic shock: new pharmacotherapy options or better trial design?The expanding role of therapeutic antibodies.Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO).The management of severe community acquired pneumonia in the intensive care unit.Management of neonatal sepsis in term newborns.Immunotherapy of Sepsis: Blind Alley or Call for Personalized Assessment?Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways.Intravenous immunoglobulin prevents release of proinflammatory cytokines in human monocytic cells stimulated with procalcitonin.Comparison of prophylactic use of intravenous immunoglobulin versus Pentaglobin® in pediatric patients after hematopoietic stem cell transplantation.
P2860
Q22305766-553B0114-5E4D-44A8-85DA-8956DD977BBAQ24198059-3C4D4FA8-F180-404A-A6A5-12EB371AC775Q28075279-F3B0EE7F-6FAD-4A7E-8548-AFFFB228DA7FQ28080025-A385F06E-F573-4B3C-9971-C5CF16E34304Q30145641-149B498C-5EAF-4C75-A632-307CC93D1DE2Q30234954-A1310CBA-27C9-4309-A013-833D3A7686B6Q30313854-767058A5-32DA-4343-B9E4-DF5B288901CFQ30820719-C679306A-82AB-460E-AABE-66C888DFB114Q33640559-FCB9CE57-4288-4437-BFF2-F1D2E6A8C702Q33676625-1F08AE98-8813-41F2-BA79-F9EFA69B71ADQ33749972-CCCD19DA-0147-42B7-9B38-21933C14DD21Q33974292-663CB25F-E53C-4C97-9ADA-22CB17A4EEE9Q34031614-4C557EA5-958E-4723-B407-072825530156Q34157657-1692BAF5-2100-4B43-9527-A77FC6164AF5Q34528210-3C694C02-C85F-4025-9F91-F5F05238D829Q34739999-75321BBC-CEAE-4029-9BBA-5087DF59BDD6Q35107079-A0FD3469-B88E-484F-A575-D6BF6FA3A85CQ35107094-F05FD4D4-A131-48CD-A8C9-445A41AAE6EFQ35559371-EA5AEDE1-3B2B-431B-A168-6987903A3E1DQ35752782-4803C7B8-6632-411D-95B9-DEB46D14F83BQ36646072-C245DB03-239E-4136-9D23-14E32BB8AF4EQ36979273-94B5F7DD-DF2E-4C9C-BB2A-2310D74F1E5EQ37084233-3BBB16EB-1820-4966-8829-A16CF60F2AE9Q37626123-730538DE-931B-4C9C-8A8E-F7BADDED44FBQ37805910-108D3839-35BC-4597-855D-912B6CCBD70CQ37910252-B3A18AEE-A385-41F5-8EDB-BD5C15B31088Q37949639-94A0D1D5-422D-4F12-9E5C-D1D51DB48CCDQ37960531-8BF51E52-21B7-45D4-B3EC-6EBCADEA076EQ37981026-84BB8403-82A2-4D2A-A81A-25757F9A93A9Q38034107-E2504963-B3C9-4ED0-9113-9C66A3113DC4Q38068423-93BA803C-A442-49DC-8B90-E693431D948AQ38085693-0473CA88-D772-46BF-B0DC-BCC21DB261AAQ38182645-F2CB5C16-8319-4219-A9C8-57F306F12DD0Q38207933-FBF1076D-0854-4873-A36D-7FA3CD13794EQ38212536-153814B5-3456-4C97-B45F-A1F88E451964Q38244140-9FDFF09A-99A6-4805-8482-E64EA3716461Q38935459-881B201D-4E5B-42C6-827C-D9783940A77CQ39340529-A06B6CB0-AB06-419A-885E-6478BFFC22A3Q39392633-4E368BC3-9D70-475E-BB6E-B9D517E31A6DQ40129026-26FF0594-9755-457F-BFDF-A8F42AA79657
P2860
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
@en
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
@nl
type
label
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
@en
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
@nl
prefLabel
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
@en
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
@nl
P2093
P1476
Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock.
@en
P2093
Axel Nierhaus
Geraldine de Heer
K Georg Kreymann
P304
P356
10.1097/01.CCM.0000295263.12774.97
P407
P577
2007-12-01T00:00:00Z